Statement of Retraction: Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
- PMID: 40178493
- PMCID: PMC12051549
- DOI: 10.1080/17435889.2025.2488633
Statement of Retraction: Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
Retraction of
-
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.Nanomedicine (Lond). 2013 Dec;8(12):1943-54. doi: 10.2217/nnm.12.200. Epub 2013 Feb 28. Nanomedicine (Lond). 2013. Retraction in: Nanomedicine (Lond). 2025 May;20(9):1071. doi: 10.1080/17435889.2025.2488633. PMID: 23448245 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources